Nanoscience and Nanotechnology

Nanomedicine & Nanopharmaceuticals

The first nanomedicines approved for use were developed from research dating back to the 1970s.Nanopharmaceuticals such as liposomes, quantum dots, dendrimers, carbon nanotubes and polymeric nanoparticles have brought considerable changes in drug delivery and the medical system. Improved therapeutic activity and reduced toxicity in the nonclinical model systems has been showed these liposomal formulations of existing drugs showed. There is a great benefit for the patients in comparison with the conventional drugs in Nanopharmaceuticals. This fact, combined with the technical challenges in commercial-scale production of nanoparticles, led to only limited investment in nanomedicines by the major pharmaceutical companies enhanced oral bioavailability, improved dose proportionality, enhanced solubility and dissolution rate, suitability for administration and reduced food effects are several advantages of these drugs.